Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS: IPIX · Delayed Price · USD
0.0101
+0.0001 (1.00%)
Apr 18, 2024, 3:48 PM EDT - Market closed
IPIX Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0.02 | 0 | 0.42 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Cost of Revenue | 0.37 | 0.38 | 0.38 | 0 | 0.37 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Gross Profit | -0.37 | -0.36 | -0.38 | 0.42 | -0.37 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Selling, General & Admin | 1.48 | 1.96 | 2 | 2.27 | 2.11 | 2.58 | 2.55 | 3.05 | 2.43 | 1.69 | Upgrade
|
| Research & Development | 1.09 | 4.81 | 7.02 | 2.79 | 4.34 | 11.37 | 12.78 | 8.95 | 10.53 | 6.34 | Upgrade
|
| Other Operating Expenses | 0.48 | -0.01 | 0.5 | 0.1 | 0.36 | 517,000 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 2.57 | 6.78 | 9.02 | 5.06 | 6.45 | 13.94 | 15.34 | 12.01 | 12.96 | 8.04 | Upgrade
|
| Operating Income | -2.94 | -6.92 | -9.02 | -4.64 | -6.45 | -13.94 | -15.34 | -12.65 | -12.96 | -8.04 | Upgrade
|
| Interest Income | 0.06 | 0.12 | 4.86 | 0.26 | 2.2 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 0.06 | 0.12 | 4.86 | 0.26 | 2.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.21 | Upgrade
|
| Other Expense / Income | 0.23 | 0.12 | 4.86 | 2.01 | 2.23 | 4.44 | -0.2 | -0.2 | -0.21 | -0 | Upgrade
|
| Pretax Income | -3.17 | -7.04 | -13.87 | -6.65 | -8.68 | -16.36 | -15.54 | -12.85 | -13.15 | -8.25 | Upgrade
|
| Income Tax | 0 | 0.12 | 4.86 | 0.36 | 0.39 | -2.22 | 0.2 | 0.2 | 0.2 | 0 | Upgrade
|
| Net Income | -3.17 | -7.16 | -18.73 | -7.01 | -9.07 | -16.36 | -15.54 | -12.85 | -13.15 | -8.25 | Upgrade
|
| Shares Outstanding (Basic) | 506 | 504 | 386 | 237 | 178 | 145 | 127 | 117 | 115 | 102 | Upgrade
|
| Shares Outstanding (Diluted) | 506 | 504 | 386 | 237 | 178 | 145 | 127 | 120 | 115 | 105 | Upgrade
|
| Shares Change | 0.38% | 30.48% | 62.73% | 33.14% | 23.33% | 13.53% | 6.15% | 4.19% | 9.56% | 10.60% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.05 | -0.03 | -0.05 | -0.11 | -0.12 | -0.11 | -0.11 | -0.08 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.05 | -0.03 | -0.05 | -0.11 | -0.12 | -0.11 | -0.11 | -0.08 | Upgrade
|
| Free Cash Flow | -2.17 | -6.36 | -9.57 | -4.25 | -6.42 | -13.4 | -12.05 | -10.3 | -13.53 | -10.18 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.02 | -0.04 | -0.09 | -0.09 | -0.09 | -0.12 | -0.10 | Upgrade
|
| Gross Margin | - | -2022.22% | - | 100.00% | - | - | - | - | - | - | Upgrade
|
| Operating Margin | - | -38450.00% | - | -1095.74% | - | - | - | - | - | - | Upgrade
|
| Profit Margin | - | -39783.33% | - | -1657.21% | - | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | -35333.33% | - | -1004.02% | - | - | - | - | - | - | Upgrade
|
| EBITDA | -2.57 | -6.4 | -8.64 | -4.16 | -5.72 | -15.75 | -14.93 | -11.58 | -12.55 | -7.75 | Upgrade
|
| EBITDA Margin | - | -35572.22% | - | -983.45% | - | - | - | - | - | - | Upgrade
|
| Depreciation & Amortization | 0.37 | 0.38 | 0.38 | 0.37 | 0.37 | 0.41 | 0.41 | 0.42 | 0.4 | 0.29 | Upgrade
|
| EBIT | -2.94 | -6.79 | -9.02 | -4.53 | -6.09 | -16.16 | -15.33 | -12 | -12.95 | -8.04 | Upgrade
|
| EBIT Margin | - | -37694.44% | - | -1071.63% | - | - | - | - | - | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.